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Barriers for HIV testing during
pregnancy in Southern Brazil
Barreiras para a realização do teste
para a detecção do HIV em gestantes
no Sul do Brasil
ABSTRACT
OBJECTIVE: To assess HIV testing rate and determine risk factors for not have
been tested during pregnancy.
METHODS: A cross-sectional study was carried out in Porto Alegre, Southern
Brazil, from December 2000 to February 2001. Socioeconomic, maternal and healthcare
variables were obtained by means of a standardized questionnaire. Crude and adjusted
odds ratios and their 95% confidence intervals were obtained in logistic regression
models.
RESULTS: A total of 1,642 mothers were interviewed. Of them, 94.3% reported
being offered HIV testing before or during pregnancy or during labor; 89 mothers
(5.4%) were not tested or did not know if they were tested. Attending fewer than six
prenatal visits, being single and younger than 18 years old were relevant barriers
preventing HIV testing. There was found a relationship between maternal schooling
and the category of prenatal care provider. Having low 22.20 (12.43-39.67) or high
3.38 (1.86-7.68). schooling and being cared in the private sector strongly reduced the
likelihood of being HIV tested.
CONCLUSIONS: The Brazilian Health Ministry’s recommendation for universal
counseling and HIV testing has been successfully implemented in the public sector.
In order to improve HIV testing coverage, new strategies need to target women cared
in the private sector especially those of low schooling.
KEYWORDS: HIV. Pregnancy. HIV antibodies. Prenatal care. HIV
infections, diagnosis.
RESUMO
OBJETIVO: Avaliar o padrão de realização do teste para a detecção do HIV e os
fatores de risco para a sua não realização durante a gestação.
MÉTODOS: Trata-se de um estudo transversal realizado em Porto Alegre, de
dezembro de 2000 a fevereiro de 2001. Foram obtidas de puérperas variáveis biológicas,
demográficas e sociais por meio de questionário padronizado. Foi elaborado modelo
de regressão logística para determinar os fatores risco para não ser testada para a
detecção do HIV.
RESULTADOS: Foram entrevistadas 1.642 mães. Destas, 94,3% informaram testadas
para o HIV. Oitenta e nove (5,4%) não foram testadas para HIV ou não sabiam se
haviam feito o teste. Realizar menos do que seis consultas pré-natais, ausência de
companheiro e idade inferior a 18 anos foram fatores de risco para não realização do
teste. Houve interação entre escolaridade materna e categoria do atendimento pré-
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natal. Baixa escolaridade 22,20 (12,43-39,67) e alta escolaridade 3,38 (1,86-7,68)
com acompanhamento pré-natal no setor privado foram condições preponderantes
para não realização do teste de detecção do HIV.
CONCLUSÕES: A testagem universal para a detecção do HIV durante o pré-natal no
setor público foi implementada com sucesso pelo Ministério da Saúde. Contudo,
novas intervenções e estratégias necessitam ser direcionadas objetivando ampliar o
acesso ao diagnóstico da infecção por HIV no setor privado.
DESCRITORES: HIV. Gravidez. Anticorpos anti-HIV. Cuidado pré-natal.
Infecções por HIV, diagnóstico.
INTRODUCTION
In Brazil, universal voluntary HIV testing has been
available for all pregnant women since 1997. Free
anti-retroviral therapy is available for all HIV-posi-
tive pregnant women from week 14 of pregnancy up
to delivery and for their newborns. In order to pro-
vide an adequate replacement for breastfeeding, in-
fant formula preparations are available during the first
six months of life at no cost.*,** The program has
had an extremely significant impact in terms of low-
ering mother-to-child HIV transmission, with a de-
crease from 926 HIV-infected newborns in 1996 to
111 in 2001.3
Some studies have estimated the coverage of HIV test-
ing among pregnant women in Brazil. One study13
was carried out before free anti-retroviral therapy was
available for all pregnant women and showed an over-
all HIV testing rate of 68% during prenatal care in the
city of Ribeirão Preto (State of São Paulo). Recently,
after free access to anti-retroviral therapy, another
study showed similar results. The coverage of HIV
testing during pregnancy was 52% nationwide, 69%
in the Southeast and 72% in the Southern region.17
Current research suggests that mothers who are HIV
infection diagnosed late in the course of their preg-
nancies or after delivery come from poor socioeco-
nomic background.20 The reasons why these women
are not being tested when anti-retroviral therapy is
available are not clear.
The present study sought to determine the coverage
of HIV testing and to identify barriers that reduce the
likelihood of HIV testing during pregnancy. The study
findings will contribute to promoting changes in prac-
tice and policy in order to improve HIV testing rate
and anti-retroviral therapy coverage. This is particu-
larly relevant given there are resources available to
address health care needs of HIV infected women and
their children.
METHODS
A cross-sectional hospital-based study was carried
out in the city of Porto Alegre, Southern Brazil, from
December 2000 to February 2001. There were
1,440,000 inhabitants in Porto Alegre in 1999.
All mothers who gave birth in the city’s three largest
public hospitals during the study period were eligible,
making it a total of 1,658 mothers. These three hospi-
tals accounted for 9,570 (41%) of 23,360 deliveries
reported in the city in 2000. Hospital deliveries corre-
sponded to 99% of all live births in the city. It was
estimated that a sample size of 1,268 subjects would
provide an odds ratio of 1.80 with 95% confidence
interval and 80% power, considering a 10% prevalence
of not being HIV tested in the unexposed group.6
Socioeconomic, maternal and medical care informa-
tion were obtained from the mothers by means of a
standardized questionnaire. Interviews were performed
after delivery by trained personnel supervised by the
research team. The socioeconomic variables were:
marital status, educational level; and the category of
prenatal care provider. Maternal variables were: moth-
er’s age and number of pregnancies including the cur-
rent one. The medical care variables were: the preg-
nancy trimester in which the first prenatal visit oc-
curred, and number of prenatal care visits.
A small amount of additional data was collected from
prenatal care records in order to confirm whether HIV
testing was performed. Less than 1% of the mothers
refused to be interviewed, and data were missing for
some mothers.
HIV testing during pregnancy care was considered
*Ministério da Saúde. Portaria Técnica Ministerial n. 874/97, de 03 de julho de 1997. Diário Oficial da União, Brasília, 04 jul 1997.
**Ministério da Saúde. Portaria Técnica Ministerial n. 709/99, de 10 de junho de 1999. Diário Oficial da União, Brasília, 11 jun 1999.
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as the dependent variable, and coded 0 if tested and
1 if not tested. Mothers (n=16; 1%) known to be
HIV-positive before the current pregnancy were ex-
cluded from the analysis. Thus, the sample com-
prised 1,642 parturient women. Pregnant women who
did not know if they were HIV tested or who were
not tested at all were defined as “not being HIV
tested”. To investigate the associations, crude and
adjusted odds ratios and their 95% confidence in-
tervals were estimated in logistic regression mod-
els. P-values for each variable were derived from the
log-likelihood ratio statistic. A conceptual model
guided the regression strategy used in the adjusted
analysis.21 According to this approach, socioeco-
nomic variables are the first events that directly or
indirectly should determine the outcome. For this
reason, the first model was adjusted only for socio-
economic variables. The second model included these
socioeconomic variables plus maternal variables. The
third model was adjusted for socioeconomic and
maternal variables plus medical care variables. Ges-
tational age was included in the last model as a con-
tinuous variable and was measured in complete weeks
according to Capurro’s method.4 The odds ratios re-
ported for socioeconomic variables were drawn from
model 1, those for maternal variables were drawn from
model 2 and those for health care variables were drawn
from the estimates derived in model 3.
Plausible interactions were tested. There was an in-
teraction between maternal schooling and the cat-
egory of prenatal care provider. To better explain this
interaction a new variable including maternal school-
ing and category of prenatal care provider together
was presented in four categories as follows: low
schooling mothers cared in the public sector, low
schooling mothers cared in the private sector, high
schooling mothers cared in the public sector and high
schooling mothers cared in the private sector. Low
schooling mothers cared in the public sector were
taken as reference.
Consent and ethical approval for the study were ob-
tained from the Ethics Committees of all three hospi-
tals. Consent was obtained individually from each
mother who participated in the study.
RESULTS
A total of 1,553 women (94.6%) reported being of-
fered HIV testing during their current pregnancy, of
which 1,549 (94.3%) were HIV tested shortly before
or during their current pregnancy. Four (0.2%) de-
clined to be tested after counseling. Eighty-nine
(5.4%) were not HIV tested during their current preg-
nancy and 48 were tested with rapid testing during
labor. Forty-one were not either offered voluntary
counseling or testing during their current pregnancy,
including 20 who were only tested before their cur-
rent pregnancy (Table 1).
The majority of women were tested in the first and
second trimesters of pregnancy. Eight women were
diagnosed as HIV-positive late in the second trimes-
ter, corresponding to 40% of the all HIV-positive
women diagnosed in the current pregnancy (Table 1).
The group of women tested by rapid test just before
delivery showed the highest percentage of HIV-posi-
Table 1 - Anti-HIV antibody testing and prevalence of HIV-positive women during pregnancy. Porto Alegre, Brazil, 2001.
Anti-HIV antibody testing Women tested (N) (%) 95% CI HIV-positive women
First trimester 539 32.8 30.5-35.2 4
Second trimester 723 44.0 41.6-46.5 8
Third trimester 219 13.3 11.7-15.1 3
Rapid test during labor 48 2.9 2.2-3.9 5
Before pregnancy 20 1.2 0.7-1.9 0
Do not know if they were tested 68 4.1 3.2-5.2 0
Not tested 21 1.3 0.8-1.9 –
Declined to be tested after counseling 4 0.2 0.1-0.6 –
Total 1,642 100 20
Table 2 - Social, maternal and medical care variables of
women attending prenatal care. Porto Alegre, Brazil, 2001.
Variable N %
Marital status
Married 1,475 90.1
Single 158 9.7
Missing data 5 0.3
Maternal schooling
Low 923 56.4
High 713 43.5
Missing data 2 0.1
Category of prenatal care provider
Public 1,401 85.5
Private 237 14.5
Maternal age (years)
18-30 1,088 66.4
31-44 357 21.8
<18 192 11.7
Missing data 1 0.1
Number of pregnancies
>3 545 33.3
2-3 688 42.0
1 405 24.7
Trimester of first prenatal care visit
First or second 1,445 88.2
Third 106 6.5
Missing data 87 5.3
Number of prenatal care visits
>5 1,040 63.5
≤5 497 30.3
Missing data 101 6.2
Total 1,638 100.0
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tive results. The overall prevalence of positive HIV
testing (including women who were tested by rapid
test) was 1.2% (95% CI: 0.1-1.9).
Table 2 shows the independent variables included in
the analysis. Mothers were predominantly married
(90.1%), and most of them had low schooling (56.4%).
Most attended prenatal care in the public sector
(85.5%) and were between 18 and 30 years of age
(66.4%), 42.0% had had two to three pregnancies,
most began prenatal care in the first or second trimes-
ter of pregnancy (88.2%) and attended more than five
prenatal care visits (63.5%).
Those with an increased likelihood of not being HIV
tested in the unadjusted analysis were single, attended
prenatal care in the private sector and had less than six
prenatal visits. In contrast, mothers with high school-
ing were at a low risk of not being tested (Table 3).
Among 237 women (14.5%) who attended prenatal
care in the private sector, four were diagnosed as HIV-
positive, a prevalence of 1.7% (95% CI: 0.1-4.2).
In the adjusted analysis, being younger than 18 years
and attending fewer than six prenatal care visits were
risk factors for not being HIV tested. Living without
a partner was marginally associated with an in-
creased risk of not being HIV tested (p-value be-
tween 0.05 and 0.10). There was an interaction be-
tween maternal schooling and the category of pre-
natal care provider. Mothers with low schooling who
were cared in the private sector had the highest risk
of not being HIV tested (OR=22.2), whereas moth-
ers with high schooling who were cared in the pri-
vate sector had 3.78 higher chance of not being HIV
tested (Table 4).
DISCUSSION
Despite the high rate of HIV testing during pregnancy,
some barriers for testing were identified, such as those
related to medical care. Having low schooling and
being cared in the private sector were most strongly
associated with reduced likelihood of being HIV
tested. Having high schooling and being cared in the
private sector also increased the risk of not being
HIV tested. Attending fewer than six prenatal visits,
being single and young (<18 years) were also rel-
evant barriers preventing HIV testing.
Despite almost universal availability of HIV testing,
socioeconomic inequalities are still preventing
women from poor backgrounds from testing, espe-
cially if they are cared in the private sector. The study
results showed that the private sector is not adequately
implementing the policy of universal HIV testing
offer: 22.8% of mothers cared in this sector were not
tested and refusal rate was only 0.2%. Conversely, for
those cared in the public sector HIV testing coverage
is almost universal (only 2.5% were not tested).
The results add to the evidence that the Brazilian
Ministry of Health has nearly overcome two major
obstacles to the systematic voluntary HIV testing of
Table 3 - Unadjusted analysis of social, maternal and medical care risk factors for not being HIV tested during pregnancy.
Porto Alegre, Brazil, 2001.
Variable % of women not tested Crude odds ratio 95% CI p-value
Marital status 0.027
Married 5.0 1
Single 9.5 2.01 1.13 3.60
Maternal schooling 0.004
Low 6.8 1
High 3.5 0.50 0.31 0.80
Category of prenatal care provider <0.001
Public 2.5 1
Private 22.8 11.52 7.33 18.11
Maternal age (years) 0.201
18-30 5.0 1
31-44 5.3 1.08 0.63 1.84
<18 8.3 1.74 0.97 3.11
Number of pregnancies 0.324
>3 5.1 1
2-3 4.8 0.93 0.55 1.56
1 6.9 1.37 0.80 2.35
Trimester of first prenatal care visit 0.228
First or second 2.6 1
Third 4.7 1.88 0.72 4.90
Number of prenatal care visits 0.011
>5 1.9 1
≤5 4.2 2.25 1.21 4.19
Maternal schooling and prenatal care provider <0.001
Low schooling and public care 2.8 1
Low schooling and private care 40.0 23.19 13.03 41.25
High schooling and public care 2.08 0.74 0.36 1.50
High schooling and private care 9.6 3.68 1.81 7.45
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pregnant women seen in developing countries: cost,
and the complex logistics of testing and treating with
zidovudine. Considering that only four mothers re-
fused to be tested after the counseling session, the
acceptance rate was similar to that found in Thailand,
Sweden and Canada2,10,23 and higher than the rate ob-
served in England and the United States (74% and
95%, respectively).7,9
The estimated prevalence of HIV-positive testing in
pregnant women in Brazil was 0.6%, which ranks
Brazil in an intermediate position between high-rate
African countries and low-rate developed coun-
tries.11,15,18,22 Porto Alegre showed a similar prevalence
when compared with other large cities in Brazil: 1.5%
in Rio de Janeiro,14 and 0.8% in Vitória.12
Despite the high HIV testing rate in the first and
second trimesters, a large number of HIV-positive
women were still diagnosed late in the third trimes-
ter. This finding highlights the importance of rapid
HIV testing as a complementary strategy for increas-
ing HIV testing and diagnosis, although a later dia-
gnosis can constitute an additional risk for mother-
to-child transmission.8 However, the use of rapid HIV
testing has a limitation because it can produce false
positive results.24
The finding of high risk of not being tested for moth-
ers cared in the private sector was unexpected. Doc-
tors may regard better-off women as being less ex-
posed to the risk of HIV infection. It can also be
speculated that doctors may also fear losing their
patients if they offer HIV testing to them because
this can be interpreted as suggestive of unsafe sexual
behavior.16 The private sector provides approxi-
mately 30% of all prenatal care in Brazil,5 thus a
policy aimed at increasing HIV testing in this sector
could have a positive impact on the mother-to-child
transmission rate.
Having an adequate number of prenatal care visits
was associated with higher rates of HIV testing, there-
fore improving access to prenatal care and increasing
the number of prenatal care visits appears to be a key
factor for increasing HIV testing rates.1,6,19
The present study showed that the Brazilian Health
Ministry’s recommendation for universal counseling
and HIV testing has been successfully implemented
in the public sector. However, those from socially
underprivileged groups and who were cared in pri-
vate sector had reduced chance of being HIV tested.
Therefore, in order to improve HIV testing, new strat-
egies need to target women cared in the private sector
especially those of low schooling. In addition, women
who attend few prenatal care visits, who are living
without a partner and are younger than 18 years of
age as well as those better-off women cared in the
private sector need to be targeted as well.
Table 4 - Adjusted models of social, maternal and medical care risk factors for not being HIV tested during pregnancy. Porto
Alegre, Brazil, 2001.
Variable Adjusted odds ratio 95% CI p-value
Marital status* 0.064
Married 1
Single 1.87 0.96 3.61
Maternal schooling and category of prenatal care provider* <0.001
Low schooling and public care 1
Low schooling and private care 22.20 12.43 39.67
High schooling and public care 0.75 0.37 1.51
High schooling and private care 3.78 1.86 7.68
Maternal age (years)** 0.079
18-30 1
31-44 0.86 0.46 1.61
<18 2.27 1.08 4.77
Number of pregnancies** 0.394
>3 1
2-3 1.09 0.58 2.03
1 1.58 0.76 3.30
Trimester of first prenatal care visit*** 0.339
First or second 1
Third 1.66 0.59 4.68
Number of prenatal care visits*** 0.009
>5 1
≤5 2.67 1.28 5.55
*Model 1: adjusted for socioeconomic variables: marital status, maternal schooling and category of prenatal care provider
**Model 2: adjusted for maternal variables: maternal age and number of pregnancies plus variables in model 1
***Model 3: adjusted for medical care variables: trimester of first prenatal care visit and number of prenatal care visits plus
variables in model 2 and also adjusted for gestational age in completed weeks
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